NYR vs RHT

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

RHT

RESONANCE FPO [RHT]

52MEDIUM

Score Breakdown

NYR RHT
Technical
72
48
Catalyst
53
53
Sentiment
50
50
Fundamental
38
82
Momentum
71
64
Risk Gate
42
42

Key Metrics

NYR Metric RHT
$134.7MMarket Cap$19.1M
545KAvg Volume (20d)308K
N/AShort InterestN/A
$1.43552-Week High$0.059
$0.09152-Week Low$0.033
+16.9%Daily Change+0.0%
$0.567Entry Price$0.040
-71.0%ROE+7.3%
-234.3%Profit Margin+5.6%

Active Signals

NYR Signals

●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 12.3% over the last 5 days
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (4 quarters) - dilution risk
●Very high P/S ratio (56.6x)
●Piotroski F-Score weak (3/9, low-confidence approx)

RHT Signals

●MACD momentum is picking up steam
●Stochastic turning bearish from a high level — caution
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.4x)
●Strong revenue growth (+53%)
●Piotroski F-Score strong (7/9, low-confidence approx)

Ask Scout AI to compare NYR and RHT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NYR Full Analysis → RHT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).